NCT01881568View on ClinicalTrials.gov

Efficacy Comparison of Topical and Intravenous Tranexamic Acid to Reduce the Number of Blood Transfusions in TKA

PHASE3CompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Blood Loss
Interventions
DRUG

Tranexamic Acid

Topical administration: 3g of Tranexamic Acid in 100mL of normal saline (0.9% sodium chloride)

DRUG

Tranexamic Acid

Intravenous administration of two dosis of Tranexamic Acid (15mg/kg of Tranexamic Acid in 100mL of normal saline each)

Trial Locations (1)

28046

Hospital Universitario La Paz, Madrid

All Listed Sponsors
lead

Hospital Universitario La Paz

OTHER

NCT01881568 - Efficacy Comparison of Topical and Intravenous Tranexamic Acid to Reduce the Number of Blood Transfusions in TKA | Biotech Hunter | Biotech Hunter